Roche Holding AG (TSX:ROG)

Market Cap	516.33B
Revenue (ttm)	108.88B
Net Income (ttm)	16.17B
Shares Out	n/a
EPS (ttm)	20.14
PE Ratio	31.93
Forward PE	18.27
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,900
Average Volume	11,741
Open	26.96
Previous Close	n/a
Day's Range	26.86 - 26.96
52-Week Range	18.42 - 26.96
Beta	n/a
RSI	74.00
Earnings Date	Jan 29, 2026

About Roche Holding AG

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand. The company offers pharma solutions in the therapeutic areas of anaemia, blood and solid tumors, dermatology, haemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It also provides in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and others; diagn...

• Industry: Other
• Founded: 1896
• Employees: 103,249
• Stock Exchange: Toronto Stock Exchange
• Ticker Symbol: ROG

Financial Performance

In 2024, Roche Holding AG's revenue was 62.40 billion, an increase of 3.23% compared to the previous year's 60.44 billion. Earnings were 8.28 billion, a decrease of -28.01%.

Financial numbers in CHF